Únete al Dr. Mark Ebell y al Dr. Michael Wilkes mientras exploran estudios médicos clave cada semana, ofreciendo perspectivas que impactan la práctica clínica en solo cinco minutos.
Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
11 mins • Apr 1, 2024
Charts
- 184Decreased by 7
- 145Decreased by 19
Episodios recientes
![](https://files.podcastos.com/shows/cf78hx/jpeg256-579ec824.jpg)
Apr 1, 2024
Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
11 mins
![](https://files.podcastos.com/shows/cf78hx/jpeg256-579ec824.jpg)
Mar 25, 2024
Episode 694: Patient reminders combined with clinician audit and feedback increases human papillomavirus vaccine uptake
6 mins
![](https://files.podcastos.com/shows/cf78hx/jpeg256-579ec824.jpg)
Mar 18, 2024
Episode 693: Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease
7 mins
![](https://files.podcastos.com/shows/cf78hx/jpeg256-579ec824.jpg)
Mar 11, 2024
Episode 692: Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age
7 mins
![](https://files.podcastos.com/shows/cf78hx/jpeg256-579ec824.jpg)
Mar 4, 2024
Episode 691: High-dose recombinant flu vaccine: NNT = 3000 to prevent one more infection, no impact on hospitalization
6 mins
![](https://files.podcastos.com/shows/cf78hx/jpeg-7bbbeb4c.jpg)
Idioma
Inglés
País
Estados Unidos
Categorías
Sitio web
Feed
Solicitar una actualización
Las actualizaciones pueden tardar unos minutos.